ASYMPTOTE GENETIC MEDICINES Trademark
Trademark Overview
On Friday, December 20, 2024, a trademark application was filed for ASYMPTOTE GENETIC MEDICINES with the United States Patent and Trademark Office. The USPTO has given the ASYMPTOTE GENETIC MEDICINES trademark a serial number of 98915361. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, December 20, 2024. This trademark is owned by Asymptote Genetic Medicines, Inc.. The ASYMPTOTE GENETIC MEDICINES trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Biological research; Biological research and analysis; Development of gene-based medicines; Gene therapy research; Laboratory research services in the field of gene expression; Medical research; Medical research services; Research in the field of gene editing technology; Research in the field of synthetic biology; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for engaging in biological, medical, and gene therapy research; Software as a service (SAAS) services, namely, hosting software for use by others for engaging in biological, medical, and gene therapy research; Providing laboratory research services in the field of gene expression, namely, cancer biology; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy
General Information
| Serial Number | 98915361 |
| Word Mark | ASYMPTOTE GENETIC MEDICINES |
| Filing Date | Friday, December 20, 2024 |
| Status | 630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER |
| Status Date | Friday, December 20, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Biological research; Biological research and analysis; Development of gene-based medicines; Gene therapy research; Laboratory research services in the field of gene expression; Medical research; Medical research services; Research in the field of gene editing technology; Research in the field of synthetic biology; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for engaging in biological, medical, and gene therapy research; Software as a service (SAAS) services, namely, hosting software for use by others for engaging in biological, medical, and gene therapy research; Providing laboratory research services in the field of gene expression, namely, cancer biology; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, December 20, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Asymptote Genetic Medicines, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Pasadena, CA 91106 |
Trademark Events
| Event Date | Event Description |
| Friday, December 20, 2024 | NEW APPLICATION ENTERED |
